Partners

Griffith Institute for Drug Discovery (Brisbane, Australia)

• Professor Kathy Andrews

Walter and Eliza Hall Institute (Melbourne, Australia)

• A Prof Boddey
• Dr Brad Sleebs

Monash Institute of Pharmaceutical Sciences (Melbourne, Australia)

• Prof Jonathan Baell

University of Sydney (Sydney, Australia)

• A Prof Matthew Todd

University of Western Australia (Perth, Australia)

• A Prof Matthew Piggott

University of New South Wales (Sydney, Australia)

• Dr Luke Hunter

Cancer Therapeutics CRC (Melbourne, Australia)

• Dr Mark Devlin

Centre for Drug Candidate Optimisation (Melbourne, Australia)

• Prof Sue Charman

University of Cape Town (Cape Town, South Africa)

• Prof Kelly Chibale

University of Virginia (Virginia, USA)

• Prof Kevin Lynch

LIMR Chemical Genomics Center (Pennsylvania, USA)

• Dr Melvin Reichman

Southwestern Medical Center (Dallas, USA)

• Prof Margaret Phillips

University of Kentucky (Kentucky, USA)

• Prof R. Kiplin Guy

Columbia University Medical Center (New York, USA)

• Prof David Fidock

University of Düsseldorf (Düsseldorf, Germany)

• Prof Thomas Kurz

University of Paris (Paris, France)

• A Prof Pierre Buffet

Istituto Superiore di Sanità (Rome, Italy)

• Dr. Pietro Alano

London School of Hygiene & Tropical Medicine (London, UK)

• Professor John Kelly

• Dr Sam Alsford

Monash University (Melbourne, Australia)

• Dr Darren Creek

Uppsala University (Uppsala, Sweden)

• A Prof Mate Erdelyi

Mahidol University (Bangkok, Thailand)

• Dr. Jetsumon Sattabongkot Prachumsri

National Center for Research in Energy and Materials (Campinas – SP, Brazil)

• Professsor Lucio Freitas-Junior

Epichem Pty Ltd (Western Australia, Australia)

• Dr Martine Keenan

Olivia Newton-John Cancer Research Institute (Victoria, Australia)

• Professor Robin Anderson

University of Strathclyde (Glasgow, UK)

• Professor Colin Suckling

 Shanghai Institute of Materia Medica (Shanghai, China)

• SIMM